A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy
Tóm tắt
The purpose of this study is to evaluate the dosimetric benefits of a proton arc technique for treating tumors of the para-aortic lymph nodes (PALN). In nine patients, a proton arc therapy (PAT) technique was compared with intensity modulated radiation therapy (IMRT) and proton beam therapy (PBT) techniques with respect to the planning target volume (PTV) and organs at risk (OAR). PTV coverage, conformity index (CI), homogeneity index (HI) and OAR doses were compared. Organ-specific radiation induced cancer risks were estimated by applying organ equivalent dose (OED) and normal tissue complication probability (NTCP). The PAT techniques showed better PTV coverage than IMRT and PBT plans. The CI obtained with PAT was 1.19 ± 0.02, which was significantly better than that for the IMRT techniques. The HI was lowest for the PAT plan and highest for IMRT. The dose to the OARs was always below the acceptable limits and comparable for all three techniques. OED results calculated based on a plateau dose–response model showed that the risk of secondary cancers in organs was much higher when IMRT or PBT were employed than when PAT was used. NTCPs of PAT to the stomach (0.29 %), small bowel (0.69 %) and liver (0.38 %) were substantially lower than those of IMRT and PBT. This study demonstrates that there is a potential role for PAT as a commercialized instrument in the future to proton therapy.
Tài liệu tham khảo
Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumors with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol. 2003;68:1–14.
Cozzi L, Clivio A, Vanetti E, Nicolini G, Fogliata A. A Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol. 2006;182:376–81.
Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer. 2005;93:849–54.
Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80:263–7.
Rechner LA, Howell RM, Zhang R, Etzel C, Lee AK, Newhauser WD. Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol. 2012;57:7117–32.
Seco J, Gu G, Marcelos T, Kooy H, Willers H. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotatic body radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;87:188–94.
Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, Suit HD. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407–21.
Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31:1249–56.
Dawson LA, Haken PKT, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol. 2001;11:240–6.
Paganetti H. Proton Therapy Physics. Boca Raton: CRC; 2012.
Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index: A review. Int J Radiat Oncol Biol Phys. 2006;64:333–42.
Shaw E, Kline R, Gillin M, Souhami L, Hirschfekd A, Dinapoli R, Martin L. Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;27:1231–9.
Schneider U, Kaser-Hotz B. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose–response relationships. Radiat Environ Biophys. 2005;44(3):235–9.
Schneider U, Lomax A, Besserer J, Pemler P, Lombriser N, Kaser-Hotz B. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2007;68(3):892–7.
Schneider U, Zwahlen D, Ross D, Kaser-Hotz B. Estimation of radiation induced cancer from three-dimensional dose distributions: concept of organ equivalent dose. Int J Radiat Oncol Biol Phys. 2005;61:1510–5.
Schneider U, Lomax A, Timmermann B. Second cancers in children treated with modern radiotherapy techniques. Radiother Oncol. 2008;89:135–40.
Lyman JT. Complication probability as assessed from dose volume histograms. Radiat Res. 1985;104:S13–9.
Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for threedimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 1991;21:137–46.
Kim JS, Yoon M, Park SY, Shin JS, Shin E, Ju SG, Han Y, Ahn YC. A Dose Volume Histogram Analyzer Program for External Beam Radiotherapy. J Korean Soc Therap Radiol Oncol. 2009;27:240–8.
Eisbruch A, Harris J, Garden AS, Chao CKS, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys. 2010;76:1333–8.
Yoon M, Ahn SH, Kim JS, Shin DH, Park SY, Lee SB, Shin KH, Cho KH. Radiation-induced cancers from modern radiotherapy techniques: Intensity-modulated radiotherapy verse proton therapy. Int J Radiat Oncol Biol Phys. 2010;77:1477–85.
Mu X, Björk-Eriksson T, Nill S, Oelfke U, Johansson K, Gagliardi G, Johansson L, Karlsson M, Zackrisson B. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma; A comparative treatment planning study. Acta Oncol. 2005;44:554–62.
Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation- induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54:824–9.
Cozzi L, Dinshaw K, Shrivastav SA, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G, Fogliata A. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89:180–91.
DeLaney TF, Kooey HM, editors. Protons and Charge Particle Radiotherapy. 1st ed. Philadelphia: Lippincott Williams and Wilkins; 2008
Hall EJ, Phil D. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7.
Alejandro CF. Arc therapy for proton pencil beams Medicalphysicsweb; 2014. http://medicalphysicsweb.org/cws/article/research/58223. Accessed 13 Aug 2014.